NEST GENOMICS
ALBANY, CA
What changed
NIH R41 · $0.3M · CARDIAC CASCADE: Cardiomyopathy and Arrhythmia Risk Dissemination through Innovative Family Sharing
10mo agoNew grantSep 19, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 39 out of 100, unchanged since the last recompute.
Little recent filing activity, or the events on file have decayed.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R41 · $301k · non-dilutive
Sep 22, 2025NEST GENOMICS · PI SNIR, MORAN · NHGRI · award ends Sep 21, 2026 · CARDIAC CASCADE: Cardiomyopathy and Arrhythmia Risk Dissemination through Innovative Family Sharing
NIH RePORTER · NIH RePORTER 11183408 (opens the source filing in a new tab)
- Grant
R42 · $1.1M · non-dilutive
Sep 19, 2024NEST GENOMICS · PI SNIR, MORAN · NHGRI · award ends Aug 31, 2027 · Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
NIH RePORTER · NIH RePORTER 11350386 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources